Want to track SNN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
SNN closed today higher at $28.97, an increase of 0.7302% from yesterday's close, completing a monthly decrease of -11.1077% or -$3.62. Over the past 12 months, SNN stock lost -11.972%.
SNN pays dividends to its shareholders, with the most recent payment made on May 27, 2026. The next announced payment will be in In 2 months on Nov 06, 2026 for a total of $0.312.
The last earnings report, released on May 06, 2026, exceeded the consensus estimates by 0%. On average, the company has fell short of earnings expectations by -0.2467%, based on the last three reports.
Smith & Nephew plc ADR has completed 2 stock splits, with the recent split occurring on Oct 15, 2014.
The company's stock is traded on 4 different exchanges and in various currencies, with the primary listing on NYSE (USD).
SNN Advances Surgical Robotics Through Imperial College Partnership
Smith+Nephew's five-year Imperial College London partnership targets less invasive robotic surgery and could speed research into clinical use.
Zacks | 1 week ago
Smith & Nephew SNATS Q2 Earnings Call Highlights
Smith & Nephew SNATS NYSE: SNN reported second-quarter underlying revenue growth of 1.6%, below management's expectations, as continued strength in Sports Medicine and ENT was offset by weakness in U.S. Orthopaedics and Advanced Wound Bioactives.
Marketbeat | 3 weeks ago
Smith & Nephew plc (SNN) Q2 2026 Earnings Call Transcript
Smith & Nephew plc (SNN) Q2 2026 Earnings Call Transcript
Seekingalpha | 4 weeks ago
Smith & Nephew plc ADR Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Curtis Ellergodt Rothschild Investment LLC | 444 | $11,787.35 | $13,377.72 | $1,590.37 | 13.49% |
| BZ Brandon Zatopek Commonwealth Equity Services LLC | 7,883 | $227,127 | $237,357.13 | $10,230.13 | 4.5% |
| JD Jim Dushek HARBOUR INVESTMENTS Inc. | 37 | $1,175.86 | $1,104.08 | -$71.78 | -6.1% |
| NA Nizar Araji National Bank Of Canada /FI/ | 7,565 | $217,575.94 | $227,819.97 | $10,244.03 | 4.71% |
| ARS Adelbert R. Sanchez Deprince Race & Zollo Inc | 360,049 | $11.17M | $10.46M | -$711,155.1 | -6.37% |
Smith & Nephew plc ADR (SNN) FAQ
What is the stock price today?
The current price is $28.97.
On which exchange is it traded?
Smith & Nephew plc ADR is listed on NYSE.
What is its stock symbol?
The ticker symbol is SNN.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 0.75%.
What is its market cap?
As of today, the market cap is 12.17B.
Has Smith & Nephew plc ADR ever had a stock split?
Smith & Nephew plc ADR had 2 splits and the recent split was on Oct 15, 2014.
Smith & Nephew plc ADR Profile
| Health Care Equipment & Supplies Industry | Healthcare Sector | Deepak S. Nath CEO | NYSE Exchange | 83175M205 CUSIP |
| GB Country | 18,362 Employees | 2 Oct 2026 Last Dividend | 16 Dec 2003 Last Split | 16 Nov 1999 IPO Date |
Overview
Smith & Nephew plc is a globally recognized company specializing in the development, manufacture, marketing, and sale of medical devices and services. Founded in 1856 and based in Watford, the United Kingdom, the company operates internationally, catering to the healthcare sector through its three main segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. Smith & Nephew's mission is to improve the quality of life for people around the world by providing innovative and effective medical solutions.
Products and Services
Smith & Nephew offers a comprehensive range of medical devices and services across various specializations:
- Knee Implant Products: Designed for knee replacement procedures, these products aim to restore knee function with durable and efficient implants.
- Hip Implants: Focused on revision procedures, these implants are essential for correcting previous surgeries and ensuring longevity and comfort.
- Trauma and Extremities Products: This range includes both internal and external devices crucial for the stabilization of severe fractures, deformity correction procedures, and other reconstruction needs.
- Sports Medicine Joint Repair: Comprising instruments, technologies, and implants for minimally invasive surgeries, these products target soft tissue injuries and degenerative conditions across various joints including the shoulder, knee, hip, and smaller joints.
- Arthroscopic Enabling Technologies: Offering fluid management equipment, high-definition cameras, digital image capture systems, scopes, light sources, monitors, and various tissue resection devices, these technologies assist in surgical procedures and visualization inside the joints.
- Ear, Nose, and Throat (ENT) Solutions: Smith & Nephew provides specialized solutions for ENT procedures, enhancing the treatment quality and comfort for patients.
- Advanced Wound Care: The company's advanced wound care products address both acute and chronic wounds, including leg wounds, diabetic ulcers, pressure ulcers, burns, and post-operative wounds. These include:
- Advanced Wound Bioactives: Featuring biologics and other bioactive technologies for debridement and dermal repair/regeneration.
- Regenerative Medicine Products: Offering solutions such as skin, bone graft, and articular cartilage substitutes aimed at facilitating natural healing and regeneration.
- Advanced Wound Devices: Includes traditional and single-use negative pressure wound therapy systems and hydrosurgery systems, which are critical for effective wound management.
Contact Information
Address: Building 5 Croxley Park Hatters Lane
Phone: 44 1923 477 100
Website: https://www.smith-nephew.com
